Speeches Shim
Today, the U.S. Agency for International Development (USAID) announced the launch of the second phase of its Environmental Restoration of the Aral Sea (ERAS II) activity. USAID will spend approximately $1.6 million to counter the adverse effects of desertification in the Aral Sea region by improving air quality and living conditions and by strengthening climate change resilience.
Istiqlol Avlodi determined that Maftuna, as a homeless single mother, was eligible for government assistance for housing and various other expenses. With USAID support, the NGO helped Maftuna submit the necessary paperwork and, not long after, she was able to get a mortgage for the purchase of a modest one-bedroom apartment.
17 October, 2022, Tashkent, Uzbekistan – The U.S. Agency for International Development (USAID) added $5.35 million in new funding to an existing Development Objective Grant Agreement (DOAG) with the Ministry of Public Education. The DOAG outlines USAID’s commitment to invest $55 million to support the Ministry’s ambitious program of comprehensive reform of the general secondary education system over the period 2019-2026.
Today, the United States Agency for International Development (USAID) launched a vocational and entrepreneurship training program for approximately 1,000 rural women who are either survivors of gender-based violence (GBV) or are at-risk for GBV. USAID will also support graduates in finding skilled employment and starting their own businesses. This initiative is part of USAID’s $3.4 million Women’s Economic Empowerment program supporting rural women in Uzbekistan through equipping them with the skills they need to enter the economy as skilled employees and entrepreneurs.
The U.S. Agency for International Development (USAID), in partnership with the Agency for Development of Pharmaceutical Industry of Uzbekistan, has facilitated the expedited registration of six tuberculosis (TB) medications over the last year and a half. With USAID technical assistance, Uzbekistan’s Ministry of Health adopted the World Health Organization (WHO)’s collaborative registration procedure for the accelerated registration of medicines (CRP) which facilitates rapid, safe access to new medicines for TB patients in Uzbekistan.
Pages
Last updated: November 10, 2022
Comment
Make a general inquiry or suggest an improvement.